Eisai Executive and Leadership Team

Shaji Procida, the President & Chief Operating Officer at Eisai, directs the daily operational execution of the pharmaceutical portfolio. Procida manages the integration of complex manufacturing processes with global supply chain logistics to ensure consistent delivery of critical medications like Aricept and Lenvima. By overseeing cross-functional teams, the President & Chief Operating Officer aligns internal resources with the broader corporate mission of improving patient outcomes. Shaji Procida drives efficiency across the organization, focusing on scaling production capabilities to meet rising demand in international markets. This leadership role involves constant collaboration with the Board to refine operational workflows and maintain high quality standards. Through rigorous oversight of internal systems, the President & Chief Operating Officer optimizes resource allocation, ensuring that the company remains agile in a competitive pharmaceutical landscape while supporting long-term growth objectives across all therapeutic areas.

Nadine Bouali, the Senior Associate, Corporate Strategy, Chief Operating Officer Office at Eisai, architects the long-term strategic framework for the organization. Bouali analyzes market trends and competitive dynamics to inform high-level decision-making regarding the expansion of the oncology and neurology pipelines. The Senior Associate, Corporate Strategy, Chief Operating Officer Office coordinates with executive leadership to translate corporate vision into actionable business plans. Nadine Bouali monitors the performance of key assets like Dayvigo and Halaven, identifying opportunities for market penetration and therapeutic advancement. By facilitating communication between the Chief Operating Officer and various business units, the Senior Associate, Corporate Strategy, Chief Operating Officer Office ensures strategic alignment across all regional operations. This role involves synthesizing complex data sets to support sustainable growth, ultimately strengthening the market position of the company through precise, data-driven planning and proactive management of corporate initiatives.

Cynthia Schwalm, the President at Eisai, provides executive oversight for the overarching corporate direction and mission. Schwalm guides the organization through complex regulatory environments, ensuring that the development of pharmaceutical products like Fycompa and Pariet adheres to global safety and efficacy standards. The President fosters a culture of innovation, encouraging the research teams to push boundaries in the treatment of autoimmune diseases and neurological disorders. Cynthia Schwalm maintains strong relationships with external stakeholders and partners to facilitate the successful commercialization of new therapies. By setting the strategic tone for the entire company, the President ensures that all departments remain focused on the core philosophy of human health care. This leadership position involves balancing immediate financial performance with the long-term goal of delivering transformative medical solutions to patients worldwide, thereby securing the future stability and reputation of the firm.

Ryusuke Ito, the Senior Group Officer, President Consumer Hhc Business Division, Chief Growth Officer Office Head at Eisai, directs the expansion of the consumer health care portfolio. Ito manages the development and marketing of products like Chocola BB plus, ensuring these offerings meet the evolving needs of health-conscious consumers. The Senior Group Officer, President Consumer Hhc Business Division, Chief Growth Officer Office Head oversees the growth strategy for the consumer division, identifying new market segments and distribution channels. Ryusuke Ito collaborates with the Chief Growth Officer Office to implement initiatives that drive revenue and increase brand visibility. By focusing on the intersection of pharmaceutical quality and consumer accessibility, the Senior Group Officer, President Consumer Hhc Business Division, Chief Growth Officer Office Head enhances the company's footprint in the over-the-counter market. This role involves constant monitoring of consumer behavior to refine product positioning and maintain a competitive edge.